Canadian Securities Regulators Release MFDA Oversight

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Canadian Securities Regulators Release MFDA Oversight Review Report

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 17, 2013) - The Canadian Securities Administrators (CSA) today released the Oversight Review Report on the performance of the Mutual Fund Dealers Association of Canada (MFDA).

This coordinated review was undertaken by the seven provincial securities regulators that recognize the MFDA: the Alberta Securities Commission, the British Columbia Securities Commission, the Financial and Consumer Affairs Authority of Saskatchewan, the Manitoba Securities Commission, the New Brunswick Securities Commission, the Nova Scotia Securities Commission, and the Ontario Securities Commission (the Recognizing Regulators).

Overall, the Recognizing Regulators are satisfied that the MFDA met the terms and conditions of the recognition orders in the areas covered during the review period.

The review involved a new, risk-based methodology that assessed the inherent risks of each functional area of the MFDA. The objectives of the review were to:

  • assess whether the MFDA was in compliance with the terms and conditions of its recognition orders;
  • determine whether the MFDA's regulatory processes were efficient, effective, consistent and fair; and
  • evaluate whether the MFDA had adequate staffing, resources and training to effectively and efficiently perform its regulatory functions.

The Oversight Review Report details the objectives, methodology, report format, scope and findings of the oversight review for the review period from January 1, 2009 to June 30, 2012. The report also includes the MFDA's responses to the report's recommendations and the Recognizing Regulators' evaluation of, and intended follow-up to, those responses.

To view the report, visit the Recognizing Regulators' websites.

The CSA, the council of securities regulators of Canada's provinces and territories, coordinates and harmonizes regulation for the Canadian capital markets.

Alberta Securities Commission Mark Dickey 403-297-4481 Ontario Securities Commission Carolyn Shaw Rimmington 416-593-2361 Autorite des marches financiers Sylvain Theberge 514-940-2176 British Columbia Securities Commission Richard Gilhooley 604-899-6713 Manitoba Securities Commission Ainsley Cunningham 204-945-4733 New Brunswick Securities Commission Wendy Connors Beckett 506-645-7745 Nova Scotia Securities Commission Tanya Wiltshire 902-424-8586 Financial and Consumer Affairs Authority of Saskatchewan Daniela Machuca 306-798-4160 The Office of the Superintendent of Securities, P.E.I. Janice Callbeck 902-368-6288 Financial Services Regulation Division of Newfoundland and Labrador 709-729-2594 Office of the Yukon Superintendent of Securities Rhonda Horte 867-667-5466 Nunavut Securities Officer Louis Arki 867-975-6587 Northwest Territories Securities Office Donn MacDougall 867-920-8984
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading